ProKidney (MEX:PROK) Other Net Income (Loss) : MXN-0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is ProKidney Other Net Income (Loss)?

ProKidney's Other Net Income (Loss) for the three months ended in Jun. 2024 was MXN0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2024 was MXN-0.00 Mil.

ProKidney's quarterly Other Net Income (Loss) declined from Dec. 2023 (MXN0.00 Mil) to Mar. 2024 (MXN-0.00 Mil) but then increased from Mar. 2024 (MXN-0.00 Mil) to Jun. 2024 (MXN0.00 Mil).

ProKidney's annual Other Net Income (Loss) declined from Dec. 2021 (MXN0.00 Mil) to Dec. 2022 (MXN0.00 Mil) but then stayed the same from Dec. 2022 (MXN0.00 Mil) to Dec. 2023 (MXN0.00 Mil).

ProKidney Other Net Income (Loss) Historical Data

The historical data trend for ProKidney's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney Other Net Income (Loss) Chart

ProKidney Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

ProKidney Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Net Income (Loss)	Get a 7-Day Free Trial										-	-	-	-	-

ProKidney Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-0.00 Mil.

ProKidney Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of ProKidney's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

ProKidney Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

PROK:USA

Address

2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103

Website

https://www.prokidney.com

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.